The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
924
June 10, 1994
View Complete Issue         Table of Contents 2019 
Aprotinin To Decrease Bleeding in Cardiac Surgery
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Aprotinin To Decrease Bleeding in Cardiac Surgery
June 10, 1994 (Issue: 924)
Aprotinin (Trasylol - Miles), an inhibitor of fibrinolysis first identified in 1930, was recently approved by the US Food and Drug Administration for intravenous use in high-risk coronary artery bypass graft (CABG) surgery to decrease bleeding and...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Aprotinin To Decrease Bleeding in Cardiac Surgery
Article code: 924b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.